Improved survival in cHL with novel agents

Blood. 2023 Jun 1;141(22):2666-2668. doi: 10.1182/blood.2023020068.
No abstract available

Publication types

  • Editorial
  • Kommentar

MeSH terms

  • Hodgkin Disease* / pathology
  • Humans
  • Transplantation, Autologous